If you are deciding what to do with Sankyo stock right now, you are definitely not alone. The conversation around Sankyo has heated up in recent months and for good reason, especially if you have been ...

During a live event, Shirish M. Gadgeel, MD, discussed different management approaches to the improve tolerability of ...

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma ...

Stocks in developed economies outside the U.S. tend to trade at lower valuations. Some of the companies are expected to expand their businesses rapidly over the next two years.

FDA designates raludotatug deruxtecan as a breakthrough therapy for treating platinum-resistant ovarian cancers, enhancing ...

The emergence of antibody–drug conjugates (ADCs), particularly trastuzumab deruxtecan (T-DXd), has redefined therapeutic ...

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum BOSTON, MA / ACCESS Newswire / September 16, ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...

Importance Little research has been done on post-COVID symptoms at 24 months postinfection and on the association these may ...

Astute Analytica stands out as a premier provider of comprehensive Shingles Vaccine Market research reports specifically tailored for the healthcare sector. Our commitment lies in delivering valuable ...

The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast ...